Home Journal Club	FAQ My Amedeo About Tranquillis Services	Flying Publisher
	Books, Journals, Podcasts, Weekly Updates, by Amedeo

Prostate Cancer

Free Subscription Articles published in Int J Cancer Retrieve available abstracts of 103 articles: HTML format Text format

Single Articles

March 2010
1. LI Q , Kuriyama S, Kakizaki M, Yan H, et al
   History of cholelithiasis and the risk of prostate cancer: The ohsaki cohort study.
   Int J Cancer. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
2. CATTARUZZA L , Fregona D, Mongiat M, Ronconi L, et al
   Antitumor activity of gold(III)-dithiocarbamato derivatives on prostate cancer cells and xenografts.
   Int J Cancer. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
3. KERKHOF M , Roobol MJ, Cuzick J, Sasieni P, et al
   Effect of the correction for non-compliance and contamination on the estimated reduction of metastatic prostate cancer within a randomized screening trial (ERSPC section rotterdam).
   Int J Cancer. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   February 2010
4. HAGMAN Z , Larne O, Edsjo A, Bjartell A, et al
   miR-34c is down regulated in prostate cancer and exerts tumor suppressive functions.
   Int J Cancer. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
5. WASYLYK C , Zambrano A, Zhao C, Brants J, et al
   Tubulin tyrosine ligase like 12, link to prostate cancer through tubulin post-translational modification and chromosome ploidy.
   Int J Cancer. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
6. SHARMA PK , Singh R, Novakovic KR, Eaton JW, et al
   CCR9-mediates PI3K/AKT dependent anti-apoptotic signals in prostate cancer cells and inhibition of CCR9-CCL25 interaction enhances the cytotoxic effects of etoposide.
   Int J Cancer. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   January 2010
7. VESTERGAARD EM , Nexo E, Torring N, Borre M, et al
   Promoter hypomethylation and upregulation of trefoil factors in prostate cancer.
   Int J Cancer. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
8. TANG Y , Li X, Liu Z, Simoneau AR, et al
   Flavokawain B, a kava chalcone, exhibits robust apoptotic mechanisms on androgen receptor-negative, hormone-refractory prostate cancer cell lines and reduces tumor growth in a preclinical model.
   Int J Cancer. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
9. SOTOMAYOR S , Munoz-Moreno L, Carmena MJ, Schally AV, et al
   Regulation of HER expression and transactivation in human prostate cancer cells by a targeted cytotoxic bombesin analog (AN-215) and a bombesin antagonist (RC-3095).
   Int J Cancer. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
10. MAHMUD SM , Franco EL, Aprikian AG
    Use of non-steroidal anti-inflammatory drugs (NSAIDs) and prostate cancer risk: A meta-analysis.
    Int J Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
11. STOCKS T , Hergens MP, Englund A, Ye W, et al
    Blood pressure, body size, and prostate cancer risk in the Swedish Construction Workers cohort.
    Int J Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
12. RAUHALA HE , Jalava SE, Isotalo J, Bracken H, et al
    miR-193b is an epigenetically regulated putative tumor suppressor in prostate cancer.
    Int J Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
13. MURTOLA TJ , Tammela TL, Maattanen L, Huhtala H, et al
    Prostate cancer and PSA among statin users in the finnish prostate cancer screening trial.
    Int J Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    December 2009
14. TAMIM HM , Hajeer AH, Boivin JF, Collet JP, et al
    Association between antibiotic use and risk of prostate cancer.
    Int J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    November 2009
15. FAN JK , Wei N, Ding M, Gu JF, et al
    Targeting gene-virotherapy for Prostate cancer by DD3-driven oncolytic virus harboring IL-24 gene.
    Int J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    October 2009
16. PANDEY M , Shukla S, Gupta S
    Promoter demethylation and chromatin remodeling by green tea polyphenols leads to re-expression of GSTP1 in human prostate cancer cells.
    Int J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
17. WICKERSHEIM A , Kerber M, de Miguel LS, Plate KH, et al
    Endothelial progenitor cells do not contribute to tumor endothelium in primary and metastatic tumors.
    Int J Cancer. 2009;125:1771-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
18. KAI L , Samuel SK, Levenson AS
    Resveratrol enhances p53 acetylation and apoptosis in prostate cancer by inhibiting MTA1/NuRD complex.
    Int J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    September 2009
19. KAWADA M , Inoue H, Ohba SI, Masuda T, et al
    Leucinostatin A inhibits prostate cancer growth through reduction of insulin-like growth factor-I expression in prostate stromal cells.
    Int J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
20. TASSIDIS H , Brokken LJ, Jirstrom K, Ehrnstrom R, et al
    Immunohistochemical detection of tyrosine phosphatase SHP-1 predicts outcome after radical prostatectomy for localized prostate cancer.
    Int J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
21. WANG W , Mize GJ, Zhang X, Takayama TK, et al
    Kallikrein-related peptidase-4 initiates tumor-stroma interactions in prostate cancer through protease-activated receptor-1.
    Int J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
22. WOLTERS T , Roobol MJ, Steyerberg EW, van den Bergh RC, et al
    The effect of study arm on prostate cancer treatment in a large screening trial (ERSPC).
    Int J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    August 2009
23. HUANG D , Casale GP, Tian J, Lele SM, et al
    UDP-glucose dehydrogenase as a novel field-specific candidate biomarker of prostate cancer.
    Int J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
24. SCHAFER A , Jung M, Mollenkopf HJ, Wagner I, et al
    Diagnostic and prognostic implications of microRNA profiling in prostate carcinoma.
    Int J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
25. ZIELINSKI AJ , Fong S, Allison J, Kawahara M, et al
    The helix-loop-helix Id-1 inhibits PSA expression in prostate cancer cells.
    Int J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
26. DESINIOTIS A , Schafer G, Klocker H, Eder IE, et al
    Enhanced anti-proliferative and pro-apoptotic effects on prostate cancer cells by simultaneously inhibiting androgen receptor and cAMP dependent protein kinase A.
    Int J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    July 2009
27. SUN A , Tang J, Terranova PF, Zhang X, et al
    AAV-delivered short-hairpin RNA for androgen receptor gene silencing induces tumor eradication of prostate cancer xenografts in nude mice: A pre-clinical study.
    Int J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
28. TANIMOTO R , Sakaguchi M, Abarzua F, Kataoka K, et al
    Down-regulation of BiP/GRP78 sensitizes resistant prostate cancer cells to gene-therapeutic overexpression of REIC/Dkk3.
    Int J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
29. SPAHN M , Kneitz S, Scholz CJ, Nico S, et al
    Expression of microRNA-221 is progressively reduced in aggressive prostate cancer and metastasis and predicts clinical recurrence.
    Int J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
30. WANG W , Yuasa T, Tsuchiya N, Ma Z, et al
    The novel tumor-suppressor Mel-18 in prostate cancer: Its functional polymorphism, expression, and clinical significance.
    Int J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
31. ABRHAM G , Volpe M, Shpungin S, Nir U, et al
    TMF/ARA160 downregulates proangiogenic genes and attenuates the progression of PC3 xenografts.
    Int J Cancer. 2009;125:43-53.
    PubMed     Text format     Related articles    Abstract available
    
    
    June 2009
32. LIU G , Taylor SA, Marrinan CH, Hsieh Y, et al
    Continuous and intermittent dosing of lonafarnib potentiates the therapeutic efficacy of docetaxel on preclinical human prostate cancer models.
    Int J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
33. MARRA M , Santini D, Meo G, Vincenzi B, et al
    CYR61 down-modulation potentiates the anti-cancer effects of zoledronic acid in androgen-independent prostate cancer cells.
    Int J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
34. SOLER M , Mancini F, Meca-Cortes O, Sanchez-Cid L, et al
    HER3 is required for the maintenance of neuregulin-dependent and -independent attributes of malignant progression in prostate cancer cells.
    Int J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
35. CHAO C , Haque R, Van Den Eeden SK, Caan BJ, et al
    Red wine consumption and risk of prostate cancer: The California Men's Health Study.
    Int J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
36. SAUER L , Nunes J, Salunkhe V, Skalska L, et al
    Sphingosine kinase 1 inhibition sensitizes hormone-resistant prostate cancer to docetaxel.
    Int J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    May 2009
37. TOROSYAN Y , Simakova O, Naga S, Mezhevaya K, et al
    Annexin-A7 protects normal prostate cells and induces distinct patterns of RB-associated cytotoxicity in androgen-sensitive and -resistant prostate cancer cells.
    Int J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
38. SINGH S , Singh R, Singh UP, Rai SN, et al
    Clinical and biological significance of CXCR5 expressed by prostate cancer specimens and cell lines.
    Int J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
39. STEINBRECHER A , Nimptsch K, Husing A, Rohrmann S, et al
    Dietary glucosinolate intake and risk of prostate cancer in the EPIC-Heidelberg cohort study.
    Int J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    April 2009
40. WALSH S , Gill C, O'Neill A, Fitzpatrick JM, et al
    Hypoxia increases normal prostate epithelial cell resistance to receptor-mediated apoptosis via AKT activation.
    Int J Cancer. 2009;124:1871-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
41. QUIROS I , Sainz RM, Hevia D, Garcia-Suarez O, et al
    Upregulation of manganese superoxide dismutase (SOD2) is a common pathway for neuroendocrine differentiation in prostate cancer cells.
    Int J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
42. DERHOVANESSIAN E , Adams V, Hahnel K, Groeger A, et al
    Pretreatment frequency of circulating IL-17(+)CD4(+) T-cells, but not Tregs, correlates with clinical response to whole-cell vaccination in prostate cancer patients.
    Int J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
43. BARVE A , Khor TO, Nair S, Reuhl K, et al
    Gamma-tocopherol-enriched mixed tocopherol diet inhibits prostate carcinogenesis in TRAMP mice.
    Int J Cancer. 2009;124:1693-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    March 2009
44. POUTAHIDIS T , Rao VP, Olipitz W, Taylor CL, et al
    CD4+ lymphocytes modulate prostate cancer progression in mice.
    Int J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
45. DE STEFANI E , Deneo-Pellegrini H, Boffetta P, Ronco AL, et al
    Dietary patterns and risk of cancer: a factor analysis in Uruguay.
    Int J Cancer. 2009;124:1391-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
46. MUCCI LA , Stark JR, Figg WD, Schumacher F, et al
    Polymorphism in endostatin, an angiogenesis inhibitor, and prostate cancer risk and survival: A prospective study.
    Int J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
47. GILBERT R , Metcalfe C, Oliver SE, Whiteman DC, et al
    Life course sun exposure and risk of prostate cancer: Population-based nested case-control study and meta-analysis.
    Int J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    February 2009
48. MU P , Nagahara S, Makita N, Tarumi Y, et al
    Systemic delivery of siRNA specific to tumor mediated by atelocollagen: Combined therapy using siRNA targeting Bcl-xL and cisplatin against prostate cancer.
    Int J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
49. JANG JH , Cotterchio M, Gallinger S, Knight JA, et al
    Family history of hormonal cancers and colorectal cancer risk: A case-control study conducted in Ontario.
    Int J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
50. DIETERLE A , Orth R, Daubrawa M, Grotemeier A, et al
    The Akt inhibitor triciribine sensitizes prostate carcinoma cells to TRAIL-induced apoptosis.
    Int J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
51. YOO KS , Nastiuk KL, Krolewski JJ
    Transforming growth factor beta1 induces apoptosis by suppressing FLICE-like inhibitory protein in DU145 prostate epithelial cells.
    Int J Cancer. 2009;124:834-42.
    PubMed     Text format     Related articles    Abstract available
    
    
    
52. NARAYANAN NK , Nargi D, Randolph C, Narayanan BA, et al
    Liposome encapsulation of curcumin and resveratrol in combination reduces prostate cancer incidence in PTEN knockout mice.
    Int J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
53. BENELLI R , Monteghirfo S, Balbi C, Barboro P, et al
    Novel antivascular efficacy of metronomic docetaxel therapy in prostate cancer: hnRNP K as a player.
    Int J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
54. XIONG SD , Yu K, Liu XH, Yin LH, et al
    Ribosome-inactivating proteins isolated from dietary bitter melon induce apoptosis and inhibit histone deacetylase-1 selectively in premalignant and malignant prostate cancer cells.
    Int J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
55. JOHNSEN NF , Tjonneland A, Thomsen BL, Christensen J, et al
    Physical activity and risk of prostate cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort.
    Int J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
56. WENSKE S , Korets R, Cronin AM, Vickers AJ, et al
    Evaluation of molecular forms of prostate-specific antigen and human kallikrein 2 in predicting biochemical failure after radical prostatectomy.
    Int J Cancer. 2009;124:659-63.
    PubMed     Text format     Related articles    Abstract available
    
    
    January 2009
57. KAPOOR S
    Inhibition of HDAC6-dependent carcinogenesis: emerging, new therapeutic options besides belinostat.
    Int J Cancer. 2009;124:509.
    PubMed     Text format     Related articles   
    
    
    December 2008
58. MA S , Chan YP, Woolcock B, Hu L, et al
    DNA fingerprinting tags novel altered chromosomal regions and identifies the involvement of SOX5 in the progression of prostate cancer.
    Int J Cancer. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
59. STARK JR , Li H, Kraft P, Kurth T, et al
    Circulating prediagnostic interleukin-6 and C-reactive protein and prostate cancer incidence and mortality.
    Int J Cancer. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
60. KAWAGUCHI Y , Miyamoto Y, Inoue T, Kaneda Y, et al
    Efficient eradication of hormone-resistant human prostate cancers by inactivated Sendai virus particle.
    Int J Cancer. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
61. ROWLANDS MA , Gunnell D, Harris R, Vatten LJ, et al
    Circulating insulin-like growth factor peptides and prostate cancer risk: A systematic review and meta-analysis.
    Int J Cancer. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
62. CHAN EO , Groome PA, Siemens DR
    Validation of quality indicators for radical prostatectomy.
    Int J Cancer. 2008;123:2651-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    November 2008
63. ZELLWEGER T , Gunther S, Zlobec I, Savic S, et al
    Tumour growth fraction measured by immunohistochemical staining of Ki67 is an independent prognostic factor in preoperative prostate biopsies with small-volume or low-grade prostate cancer.
    Int J Cancer. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
64. WILSON KM , Balter K, Adami HO, Gronberg H, et al
    Acrylamide exposure measured by food frequency questionnaire and hemoglobin adduct levels and prostate cancer risk in the Cancer of the Prostate in Sweden Study.
    Int J Cancer. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
65. SUTCLIFFE S , Alderete JF, Till C, Goodman PJ, et al
    Trichomonosis and subsequent risk of prostate cancer in the Prostate Cancer Prevention Trial.
    Int J Cancer. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
66. SWAMI S , Krishnan AV, Moreno J, Bhattacharyya RS, et al
    Inhibition of prostaglandin synthesis and actions by genistein in human prostate cancer cells and by soy isoflavones in prostate cancer patients.
    Int J Cancer. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
67. BROOKS KJ , Coleman EJ, Vitetta ES
    The antitumor activity of an anti-CD54 antibody in SCID mice xenografted with human breast, prostate, non-small cell lung, and pancreatic tumor cell lines.
    Int J Cancer. 2008;123:2438-45.
    PubMed     Text format     Related articles    Abstract available
    
    
    
68. LAURILA M , Tammela TL, Auvinen A, Isola J, et al
    Biological aggressiveness of prostate cancer in the Finnish screening trial.
    Int J Cancer. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
69. BEIKI O , Ekbom A, Allebeck P, Moradi T, et al
    Risk of prostate cancer among Swedish-born and foreign-born men in Sweden, 1961-2004.
    Int J Cancer. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
70. ZHANG X , Huang X, Olumi AF
    Repression of NF-kappaB and activation of AP-1 enhance apoptosis in prostate cancer cells.
    Int J Cancer. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
71. RIETHDORF S , Wikman H, Pantel K
    Review: Biological relevance of disseminated tumor cells in cancer patients.
    Int J Cancer. 2008;123:1991-2006.
    PubMed     Text format     Related articles    Abstract available
    
    
    October 2008
72. TANG Y , Wang MT, Chen Y, Yang D, et al
    Downregulation of vascular endothelial growth factor and induction of tumor dormancy by 15-lipoxygenase-2 in prostate cancer.
    Int J Cancer. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
73. LEGRIER ME , Guyader C, Ceraline J, Dutrillaux B, et al
    Hormone escape is associated with genomic instability in a human prostate cancer model.
    Int J Cancer. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
74. SOERJOMATARAM I , de Vries E
    Response: Risk of prostate, breast and colorectal cancer after skin cancer diagnosis.
    Int J Cancer. 2008.
    PubMed     Text format     Related articles   
    
    
    
75. POLYTARCHOU C , Hatziapostolou M, Poimenidi E, Mikelis C, et al
    Nitric oxide stimulates migration of human endothelial and prostate cancer cells through up-regulation of pleiotrophin expression and its receptor protein tyrosine phosphatase beta/zeta.
    Int J Cancer. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
76. STEWART GD , Nanda J, Brown DJ, Riddick AC, et al
    NO-sulindac inhibits the hypoxia response of PC-3 prostate cancer cells via the AKt signalling pathway.
    Int J Cancer. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
77. INOKUCHI J , Narula N, Yee DS, Skarecky DW, et al
    Annexin A2 positively contributes to the malignant phenotype and secretion of IL-6 in DU145 prostate cancer cells.
    Int J Cancer. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
78. JALAVA SE , Porkka KP, Rauhala HE, Isotalo J, et al
    TCEB1 promotes invasion of prostate cancer cells.
    Int J Cancer. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
79. MOORE SC , Leitzmann MF, Albanes D, Weinstein SJ, et al
    Adipokine genes and prostate cancer risk.
    Int J Cancer. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
80. KASPER JS , Liu Y, Giovannucci E
    Diabetes mellitus and risk of prostate cancer in the health professionals follow-up study.
    Int J Cancer. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    September 2008
81. GUAN M , Xu C, Zhang F, Ye C, et al
    Aberrant methylation of EphA7 in human prostate cancer and its relation to clinicopathologic features.
    Int J Cancer. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
82. DASHEVSKY O , Varon D, Brill A
    Platelet-derived microparticles promote invasiveness of prostate cancer cells via upregulation of MMP-2 production.
    Int J Cancer. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
83. SINGH-GUPTA V , Zhang H, Banerjee S, Kong D, et al
    Radiation-induced HIF-1alpha cell survival pathway is inhibited by soy isoflavones in prostate cancer cells.
    Int J Cancer. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
84. SUZUKI R , Allen NE, Key TJ, Appleby PN, et al
    A prospective analysis of the association between dietary fiber intake and prostate cancer risk in EPIC.
    Int J Cancer. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
85. FUJITA K , Ewing CM, Chan DY, Mangold LA, et al
    Endoglin (CD105) as a urinary and serum marker of prostate cancer.
    Int J Cancer. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
86. DEEP G , Raina K, Singh RP, Oberlies NH, et al
    Isosilibinin inhibits advanced human prostate cancer growth in athymic nude mice: Comparison with silymarin and silibinin.
    Int J Cancer. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
87. BJORKMAN M , Iljin K, Halonen P, Sara H, et al
    Defining the molecular action of HDAC inhibitors and synergism with androgen deprivation in ERG-positive prostate cancer.
    Int J Cancer. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
88. BOORMANS JL , Hermans KG, van Leenders GJ, Trapman J, et al
    An activating mutation in AKT1 in human prostate cancer.
    Int J Cancer. 2008.
    PubMed     Text format     Related articles   
    
    
    
89. LEVI F , Randimbison L, Te VC, Conconi MM, et al
    Risk of prostate, breast and colorectal cancer after skin cancer diagnosis.
    Int J Cancer. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
90. ISHARWAL S , Miller MC, Epstein JI, Mangold LA, et al
    Prognostic value of Her-2/neu and DNA index for progression, metastasis and prostate cancer-specific death in men with long-term follow-up after radical prostatectomy.
    Int J Cancer. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
91. WANG W , Li Y, Li Y, Hong A, et al
    NDRG3 is an androgen regulated and prostate enriched gene that promotes in vitro and in vivo prostate cancer cell growth.
    Int J Cancer. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
92. KIM JW , Cheng Y, Liu W, Li T, et al
    Genetic and epigenetic inactivation of LPL gene in human prostate cancer.
    Int J Cancer. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    August 2008
93. MA Z , Tsuchiya N, Yuasa T, Inoue T, et al
    Polymorphisms of fibroblast growth factor receptor 4 have association with the development of prostate cancer and benign prostatic hyperplasia and the progression of prostate cancer in a Japanese population.
    Int J Cancer. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
94. STEVENS VL , Hsing AW, Talbot JT, Zheng SL, et al
    Genetic variation in the toll-like receptor gene cluster (TLR10-TLR1-TLR6) and prostate cancer risk.
    Int J Cancer. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
95. SAUVANT C , Nowak M, Wirth C, Schneider B, et al
    Acidosis induces multi-drug resistance in rat prostate cancer cells (AT1) in vitro and in vivo by increasing the activity of the p-glycoprotein via activation of p38.
    Int J Cancer. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
96. PALAYOOR ST , Mitchell JB, Cerna D, Degraff W, et al
    PX-478, an inhibitor of hypoxia-inducible factor-1alpha, enhances radiosensitivity of prostate carcinoma cells.
    Int J Cancer. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
97. LIAO J , Li X, Koh AJ, Berry JE, et al
    Tumor expressed PTHrP facilitates prostate cancer-induced osteoblastic lesions.
    Int J Cancer. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
98. FLORYK D , Thompson TC
    Antiproliferative effects of AVN944, a novel inosine 5-monophosphate dehydrogenase inhibitor, in prostate cancer cells.
    Int J Cancer. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    July 2008
99. MARTIN RM , Vatten L, Gunnell D, Romundstad P, et al
    Lower urinary tract symptoms and risk of prostate cancer: The HUNT 2 Cohort, Norway.
    Int J Cancer. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
100. HE W , Kularatne SA, Kalli KR, Prendergast FG, et al
     Quantitation of circulating tumor cells in blood samples from ovarian and prostate cancer patients using tumor-specific fluorescent ligands.
     Int J Cancer. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
101. RAUHALA HE , Porkka KP, Saramaki OR, Tammela TL, et al
     Clusterin is epigenetically regulated in prostate cancer.
     Int J Cancer. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
102. PLATZ EA , Clinton SK, Giovannucci E
     Association between plasma cholesterol and prostate cancer in the PSA era.
     Int J Cancer. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     June 2008
103. BAO BY , Ting HJ, Hsu JW, Lee YF, et al
     Protective role of 1 alpha, 25-dihydroxyvitamin D3 against oxidative stress in nonmalignant human prostate epithelial cells.
     Int J Cancer. 2008;122:2699-706.
     PubMed     Text format     Related articles    Abstract available
     
     

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: